Literature DB >> 11076692

(13)C NMR and electron ionization mass spectrometric data-activity relationship model of estrogen receptor binding.

R D Beger1, J P Freeman, J O Lay, J G Wilkes, D W Miller.   

Abstract

Two Spectroscopic Data-Activity Relationship (SDAR) models based on (13)C nuclear magnetic resonance (NMR) and electron ionization mass spectra (EI MS) data were developed for 108 compounds whose relative binding affinities (RBA) to the estrogen receptor are known. The (13)C NMR and EI MS data were used as spectrometric digital fingerprints to reflect the electronic and structural characteristics of the compounds. Both SDAR models segregated the 108 compounds into 20 strong, 15 medium, and 73 weak relative binding classifications. The first SDAR model, based on (13)C NMR data alone, gave a leave-one-out (LOO) cross-validation of 75.0%. The second SDAR model, based on a composite of (13)C NMR and EI MS data, gave a LOO cross-validation of 82.4%. Many of the misidentifications from the cross-validations were between medium and weak classifications, where there were fewer specific spectrometric characteristics to identify the relationship of spectra to estrogen receptor binding. Real and predicted (13)C NMR chemical shifts were used to test the predictive behavior of both SDAR models. The ease of use and speed of SDAR modeling may facilitate their use with other toxicological endpoints.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076692     DOI: 10.1006/taap.2000.9043

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  2 in total

1.  Developing 13C NMR quantitative spectrometric data-activity relationship (QSDAR) models of steroid binding to the corticosteroid binding globulin.

Authors:  R D Beger; J G Wilkes
Journal:  J Comput Aided Mol Des       Date:  2001-07       Impact factor: 3.686

2.  Modeling chemical interaction profiles: I. Spectral data-activity relationship and structure-activity relationship models for inhibitors and non-inhibitors of cytochrome P450 CYP3A4 and CYP2D6 isozymes.

Authors:  Brooks McPhail; Yunfeng Tie; Huixiao Hong; Bruce A Pearce; Laura K Schnackenberg; Weigong Ge; Luis G Valerio; James C Fuscoe; Weida Tong; Dan A Buzatu; Jon G Wilkes; Bruce A Fowler; Eugene Demchuk; Richard D Beger
Journal:  Molecules       Date:  2012-03-15       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.